Recipharm AB (publ) Short Interest Ratio and Short Volume

Short interest is the volume of Recipharm AB (publ) shares that have been sold short but have not yet been closed out or covered. As of December 31st, investors have sold 113,000 shares of RCPHF short. 0.00% of Recipharm AB (publ)'s shares are currently sold short. View details.

Recipharm AB (publ) saw a increase in short interest during the month of December. As of December 31st, there was short interest totaling 113,000 shares, an increase of 4,813.0% from the previous total of 2,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.00% of Recipharm AB (publ)'s shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Recipharm AB (publ): Abattis Bioceuticals Corp. (0.00%), Alaric Co. (0.00%), Algernon Pharmaceuticals Inc. (0.00%), Almirall, S.A. (0.00%), Ascletis Pharma Inc. (0.00%), AXIM Biotechnologies, Inc. (0.00%), BerGenBio ASA (0.00%), Cannabics Pharmaceuticals Inc. (0.00%), Cerebain Biotech Corp. (0.00%), and Creative Medical Technology Holdings, Inc. (0.00%).

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($5.18 billion), ViacomCBS Inc. ($4.71 billion), Analog Devices, Inc. ($4.45 billion), Aon Plc ($4.28 billion), Snap Inc. ($3.70 billion), Moderna, Inc. ($3.00 billion), The Clorox Company ($2.46 billion), Peloton Interactive, Inc. ($2.40 billion), The Kroger Co. ($2.38 billion), and Expedia Group, Inc. ($2.37 billion). View all of the most shorted stocks.

Short selling RCPHF is an investing strategy that aims to generate trading profit from Recipharm AB (publ) as its price is falling. To short Recipharm AB (publ) stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Recipharm AB (publ) will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Recipharm AB (publ) occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RCPHF, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RCPHF, twice per month. The most recent reporting period available is December, 31 2020.